The pharmaceutical landscape for glucose is changing, and these patches represent a promising advance. Unlike subcutaneous injections, this approach offers a simpler way to administer GLP-1 therapies. These transdermal systems steadily release the drug through the epidermis offering a stable level of the active agent, which can optimize glucose … Read More